After surprise pharmacy audit, county plans in-house destruction of certain controlled substances to cut costs
Get AI-powered insights, summaries, and transcripts
Subscribe
Summary
Staff reported a surprise Kansas Board of Pharmacy audit went well and proposed using a DEA-approved in-house destruction process for scheduled II–IV medications, estimating annual savings of $500–$1,000 and confirming staff procured needed chemicals.
On Dec. 30 the Kansas Board of Pharmacy conducted an unscheduled audit of the county’s controlled substances, county staff reported on Jan. 14. The audit returned no adverse findings, staff said, and revealed a DEA-authorized pathway to destroy scheduled II–IV medications in-house rather than sending them to a reverse distributor.
Paul, who briefed the commissioners, said the county can meet DEA requirements while performing destruction internally and estimated savings of roughly $500–$1,000 per year. "We plan on starting doing that in house," Paul said, adding that the required chemical had already been procured.
The board did not take a formal vote on the change at the Jan. 14 meeting. Paul also asked whether commission reports from his department could return to a monthly cadence now that data collection is handled through ImageTrend; commissioners agreed to trial monthly reports and consider using the consent agenda after three months if appropriate.
Staff said they would implement the in-house destruction process in compliance with DEA and Kansas Board of Pharmacy requirements and would bring any procedural updates or reporting changes back to the commission as needed.